Improved quality of life in patients with GEP-NETs treated with 177Lu-dotatate

被引：0
|
作者：
Saravana-Bawan, B. [1 ]
Wieler, M. [2 ]
McMullen, T. [1 ]
McEwan, A. [2 ]
机构：
[1] Univ Alberta, Dept Surg, Edmonton, AB, Canada
[2] Univ Alberta, Cross Canc Inst, Dept Oncol, Edmonton, AB, Canada
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
基金：
加拿大健康研究院; 加拿大创新基金会;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1327P
引用
收藏
页数：1
相关论文
共 50 条
  • [31] 177Lu-DOTATATE therapy in progressive meningioma
    Roll, W.
    Muether, M.
    Zinnhardt, B.
    Stegger, L.
    Schaefers, M.
    Weckesser, M.
    Stummer, W.
    Rahbar, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S644 - S644
  • [32] Neuroendocrine Tumor Therapy: 177Lu-DOTATATE
    Mittra, Erik S.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (02) : 278 - 285
  • [33] Additional Lesions Detected in Therapeutic Scans with 177Lu-DOTATATE Reflect Higher Affinity of 177Lu-DOTATATE for Somatostatin Receptors
    Mirzaei, Siroos
    Bastati, Brigitte
    Lipp, Rainer W.
    Knoll, Peter
    Zojer, Niklas
    Ludwig, Heinz
    ONCOLOGY, 2011, 80 (5-6) : 326 - 329
  • [34] Tratamiento con 177Lu-DOTATATE: pasado, presente y futuro Treatment with 177Lu-DOTATATE: Past, present and future
    Estorch, M.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2017, 36 (02): : 69 - 71
  • [35] 177Lu-Dotatate Re-Treatment in G1-G2 Gastro-Entero-Pancreatic (GEP) NETs
    Stefano, S.
    Maddalena, S.
    Ianniello, A.
    Nicolini, S.
    Caroli, P.
    Ibrahim, T.
    Donati, C.
    D'Errico, V
    Monti, M.
    Paganelli, G.
    NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 139 - 139
  • [36] Gallbladder Uptake Mimicking Liver Metastasis on 177Lu-DOTATATE Posttherapy Scan Gallbladder Uptake on 177Lu-DOTATATE Scan
    Araz, Mine
    Baltacioglu, Muhammet Halil
    Saglam, Sezer
    Ozguven, Mehmet Ali
    Kucuk, Nuriye Ozlem
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (03) : e154 - e155
  • [37] Simple and reliable chromatographic technique for the quality control of 177Lu-DOTATATE
    Urbano, N
    Tesoriere, G
    Papi, S
    Paganelli, G
    Chinol, M
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S388 - S389
  • [38] A multicenter phase 2 randomised controlled trial comparing 177Lu-Dotatate and capecitabine combination treatment with 177Lu-Dotatate in neuroendocrine tumor patients
    Becx, M.
    Hofland, J.
    Nonnekens, J.
    Krenning, E.
    Wyld, D.
    Verburg, F.
    Brabander, T.
    de Herder, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S122 - S123
  • [39] Administration of 177Lu-PSMA-617 as Compared to 177Lu-Dotatate
    Patel, P.
    McCall, K.
    MEDICAL PHYSICS, 2022, 49 (06) : E811 - E812
  • [40] Use of PERCIST and RECIST for response evaluation in patients with neuroendocrine tumors treated with 177Lu-DOTATATE
    Gupta, Santosh
    Singla, Suhas
    Chakroborty, Sudipta
    Banerjee, Sharmila
    Das, Tapas
    Venkatesh, Meera
    Damle, Nishikant
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
12345